Detalhe da pesquisa
1.
Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study.
Lancet Oncol
; 21(11): 1513-1525, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926841
2.
Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis.
Haematologica
; 107(3): 774-775, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35229573
3.
Isatuximab plus pomalidomide and dexamethasone in elderly patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis.
Haematologica
; 106(4): 1182-1187, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32586908
4.
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab.
Blood Cancer J
; 11(5): 89, 2021 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33980831